StonvexLoading…
StonvexCore line items from GTN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.10B | $3.64B | $3.28B | $3.68B |
Operating Income | $392.00M | $851.00M | $383.00M | $990.00M |
Net Income | $-85.00M | $375.00M | $-76.00M | $455.00M |
EPS (Diluted) | $-1.41 | $3.36 | $-1.39 | $4.33 |
Total Assets | $10.44B | $10.54B | $10.64B | $11.15B |
Total Liabilities | $7.63B | $7.61B | $8.02B | $8.39B |
Cash & Equivalents | $368.00M | $135.00M | $21.00M | $61.00M |
Free Cash Flow OCF − CapEx | $181.00M | $608.00M | $300.00M | $393.00M |
Shares Outstanding | 97.00M | 96.00M | 92.00M | 93.00M |